| Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health PA Flume, BP O'Sullivan, KA Robinson, CH Goss, PJ Mogayzel Jr, ... American journal of respiratory and critical care medicine 176 (10), 957-969, 2007 | 875* | 2007 |
| Cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations PA Flume, PJ Mogayzel Jr, KA Robinson, CH Goss, RL Rosenblatt, ... American journal of respiratory and critical care medicine 180 (9), 802-808, 2009 | 825 | 2009 |
| The future of cystic fibrosis care: a global perspective SC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ... The Lancet Respiratory Medicine 8 (1), 65-124, 2020 | 789 | 2020 |
| Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation DB Sanders, RCL Bittner, M Rosenfeld, LR Hoffman, GJ Redding, ... American journal of respiratory and critical care medicine 182 (5), 627-632, 2010 | 568 | 2010 |
| Exacerbations in cystic fibrosis· 1: epidemiology and pathogenesis CH Goss, JL Burns Thorax 62 (4), 360-367, 2007 | 543 | 2007 |
| Hospital volume and the outcomes of mechanical ventilation JM Kahn, CH Goss, PJ Heagerty, AA Kramer, CR O'Brien, GD Rubenfeld New England Journal of Medicine 355 (1), 41-50, 2006 | 534 | 2006 |
| Incidence of acute lung injury in the United States CH Goss, RG Brower, LD Hudson, GD Rubenfeld Critical care medicine 31 (6), 1607-1611, 2003 | 493 | 2003 |
| Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry T MacKenzie, AH Gifford, KA Sabadosa, HB Quinton, EA Knapp, CH Goss, ... Annals of internal medicine 161 (4), 233-241, 2014 | 414 | 2014 |
| Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial L Saiman, M Anstead, N Mayer-Hamblett, LC Lands, M Kloster, ... Jama 303 (17), 1707-1715, 2010 | 389 | 2010 |
| Respiratory Outbreak of Mycobacterium abscessus Subspecies massiliense in a Lung Transplant and Cystic Fibrosis Center ML Aitken, A Limaye, P Pottinger, E Whimbey, CH Goss, MR Tonelli, ... American journal of respiratory and critical care medicine 185 (2), 231-232, 2012 | 351 | 2012 |
| Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax PA Flume, PJ Mogayzel Jr, KA Robinson, RL Rosenblatt, L Quittell, ... American journal of respiratory and critical care medicine 182 (3), 298-306, 2010 | 324 | 2010 |
| Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality N Mayer-Hamblett, M Rosenfeld, J Emerson, CH Goss, ML Aitken American journal of respiratory and critical care medicine 166 (12), 1550-1555, 2002 | 314 | 2002 |
| Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR … MW Konstan, EF McKone, RB Moss, G Marigowda, S Tian, D Waltz, ... The lancet Respiratory medicine 5 (2), 107-118, 2017 | 311 | 2017 |
| Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis CH Goss, SA Newsom, JS Schildcrout, L Sheppard, JD Kaufman American journal of respiratory and critical care medicine 169 (7), 816-821, 2004 | 308 | 2004 |
| The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry EA Knapp, AK Fink, CH Goss, A Sewall, J Ostrenga, C Dowd, A Elbert, ... Annals of the American Thoracic Society 13 (7), 1173-1179, 2016 | 298 | 2016 |
| CFTR genotype as a predictor of prognosis in cystic fibrosis EF McKone, CH Goss, ML Aitken Chest 130 (5), 1441-1447, 2006 | 297 | 2006 |
| Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis DB Sanders, RCL Bittner, M Rosenfeld, GJ Redding, CH Goss Pediatric pulmonology 46 (4), 393-400, 2011 | 289 | 2011 |
| Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection JP Clancy, L Dupont, MW Konstan, J Billings, S Fustik, CH Goss, J Lymp, ... Thorax 68 (9), 818-825, 2013 | 286 | 2013 |
| Staphylococcus aureus and MRSA in cystic fibrosis CH Goss, MS Muhlebach Journal of Cystic fibrosis 10 (5), 298-306, 2011 | 273 | 2011 |
| Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections CH Goss, Y Kaneko, L Khuu, GD Anderson, S Ravishankar, ML Aitken, ... Science translational medicine 10 (460), eaat7520, 2018 | 265 | 2018 |
Patrick FlumeMedical University of South CarolinaVerified email at MUSC.EDU
